PJ 001
Alternative Names: PJ-001Latest Information Update: 27 Dec 2024
Price :
$50 *
At a glance
- Originator Chongqing Peg-Bio Biopharm
- Class Antihyperglycaemics; Hepatoprotectants; Insulins; Pancreatic hormones
- Mechanism of Action Insulin receptor agonists; Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Diabetes mellitus
Most Recent Events
- 21 Oct 2024 Phase-I clinical trials in Diabetes mellitus (SC) prior to October 2024 (Chongqing Peg-Bio Biopharm, October 2024)
- 21 Oct 2024 Preregistration for Diabetes mellitus (SC) prior to October 2024 (Chongqing Peg-Bio Biopharm, October 2024)